Cargando…

The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study

Background: The association between giant cell arteritis (GCA) and malignancies had been widely investigated with studies reporting conflicting results. Therefore, in this study, we aimed to investigate this association using a large nationwide electronic database. Methods: This study was designed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dar, Lior, Ben-Shabat, Niv, Tiosano, Shmuel, Watad, Abdulla, McGonagle, Dennis, Komaneshter, Doron, Cohen, Arnon, Bragazzi, Nicola Luigi, Amital, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306706/
https://www.ncbi.nlm.nih.gov/pubmed/34300046
http://dx.doi.org/10.3390/ijerph18147595
_version_ 1783727875217686528
author Dar, Lior
Ben-Shabat, Niv
Tiosano, Shmuel
Watad, Abdulla
McGonagle, Dennis
Komaneshter, Doron
Cohen, Arnon
Bragazzi, Nicola Luigi
Amital, Howard
author_facet Dar, Lior
Ben-Shabat, Niv
Tiosano, Shmuel
Watad, Abdulla
McGonagle, Dennis
Komaneshter, Doron
Cohen, Arnon
Bragazzi, Nicola Luigi
Amital, Howard
author_sort Dar, Lior
collection PubMed
description Background: The association between giant cell arteritis (GCA) and malignancies had been widely investigated with studies reporting conflicting results. Therefore, in this study, we aimed to investigate this association using a large nationwide electronic database. Methods: This study was designed as a retrospective cohort study including GCA patients first diagnosed between 2002–2017 and age, sex and enrollment time-matched controls. Follow-up began at the date of first GCA-diagnosis and continued until first diagnosis of malignancy, death or end of study follow-up. Results: The study enrolled 7213 GCA patients and 32,987 age- and sex-matched controls. The mean age of GCA diagnosis was 72.3 (SD 9.9) years and 69.1% were women. During the follow-up period, 659 (9.1%) of GCA patients were diagnosed with solid malignancies and 144 (2.0%) were diagnosed with hematologic malignancies. In cox-multivariate-analysis the risk of solid- malignancies (HR = 1.12 [95%CI: 1.02–1.22]), specifically renal neoplasms (HR = 1.60 [95%CI: 1.15–2.23]) and sarcomas (HR = 2.14 [95%CI: 1.41–3.24]), and the risk of hematologic malignancies (HR = 2.02 [95%CI: 1.66–2.47]), specifically acute leukemias (HR = 1.81 [95%CI: 1.06–3.07]), chronic leukemias (HR = 1.82 [95%CI: 1.19–2.77]), Hodgkin’s lymphomas (HR = 2.42 [95%CI: 1.12–5.20]), non-Hodgkin’s-lymphomas (HR = 1.66: [95%CI 1.21–2.29]) and multiple myeloma(HR = 2.40 [95%CI: 1.63–3.53]) were significantly increased in GCA patients compared to controls. Older age at GCA-diagnosis (HR = 1.36 [95%CI: 1.25–1.47]), male-gender (HR = 1.46 [95%CI: 1.24–1.72]), smoking (HR = 1.25 [95%CI: 1.04–1.51]) and medium-high socioeconomic status (HR = 1.27 [95%CI: 1.07–1.50]) were independently associated with solid malignancy while age (HR = 1.47 [95%CI: 1.22–1.77]) and male-gender (HR = 1.61 [95%CI: 1.14–2.29]) alone were independently associated with hematologic- malignancies. Conclusion: our study demonstrated higher incidence of hematologic and solid malignancies in GCA patients. Specifically, leukemia, lymphoma, multiple myeloma, kidney malignancies, and sarcomas. Age and male gender were independent risk factors for hematological malignancies among GCA patients, while for solid malignancies, smoking and SES were risk factors as well.
format Online
Article
Text
id pubmed-8306706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83067062021-07-25 The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study Dar, Lior Ben-Shabat, Niv Tiosano, Shmuel Watad, Abdulla McGonagle, Dennis Komaneshter, Doron Cohen, Arnon Bragazzi, Nicola Luigi Amital, Howard Int J Environ Res Public Health Article Background: The association between giant cell arteritis (GCA) and malignancies had been widely investigated with studies reporting conflicting results. Therefore, in this study, we aimed to investigate this association using a large nationwide electronic database. Methods: This study was designed as a retrospective cohort study including GCA patients first diagnosed between 2002–2017 and age, sex and enrollment time-matched controls. Follow-up began at the date of first GCA-diagnosis and continued until first diagnosis of malignancy, death or end of study follow-up. Results: The study enrolled 7213 GCA patients and 32,987 age- and sex-matched controls. The mean age of GCA diagnosis was 72.3 (SD 9.9) years and 69.1% were women. During the follow-up period, 659 (9.1%) of GCA patients were diagnosed with solid malignancies and 144 (2.0%) were diagnosed with hematologic malignancies. In cox-multivariate-analysis the risk of solid- malignancies (HR = 1.12 [95%CI: 1.02–1.22]), specifically renal neoplasms (HR = 1.60 [95%CI: 1.15–2.23]) and sarcomas (HR = 2.14 [95%CI: 1.41–3.24]), and the risk of hematologic malignancies (HR = 2.02 [95%CI: 1.66–2.47]), specifically acute leukemias (HR = 1.81 [95%CI: 1.06–3.07]), chronic leukemias (HR = 1.82 [95%CI: 1.19–2.77]), Hodgkin’s lymphomas (HR = 2.42 [95%CI: 1.12–5.20]), non-Hodgkin’s-lymphomas (HR = 1.66: [95%CI 1.21–2.29]) and multiple myeloma(HR = 2.40 [95%CI: 1.63–3.53]) were significantly increased in GCA patients compared to controls. Older age at GCA-diagnosis (HR = 1.36 [95%CI: 1.25–1.47]), male-gender (HR = 1.46 [95%CI: 1.24–1.72]), smoking (HR = 1.25 [95%CI: 1.04–1.51]) and medium-high socioeconomic status (HR = 1.27 [95%CI: 1.07–1.50]) were independently associated with solid malignancy while age (HR = 1.47 [95%CI: 1.22–1.77]) and male-gender (HR = 1.61 [95%CI: 1.14–2.29]) alone were independently associated with hematologic- malignancies. Conclusion: our study demonstrated higher incidence of hematologic and solid malignancies in GCA patients. Specifically, leukemia, lymphoma, multiple myeloma, kidney malignancies, and sarcomas. Age and male gender were independent risk factors for hematological malignancies among GCA patients, while for solid malignancies, smoking and SES were risk factors as well. MDPI 2021-07-16 /pmc/articles/PMC8306706/ /pubmed/34300046 http://dx.doi.org/10.3390/ijerph18147595 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dar, Lior
Ben-Shabat, Niv
Tiosano, Shmuel
Watad, Abdulla
McGonagle, Dennis
Komaneshter, Doron
Cohen, Arnon
Bragazzi, Nicola Luigi
Amital, Howard
The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study
title The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study
title_full The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study
title_fullStr The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study
title_full_unstemmed The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study
title_short The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study
title_sort incidence and predictors of solid- and hematological malignancies in patients with giant cell arteritis: a large real-world database study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306706/
https://www.ncbi.nlm.nih.gov/pubmed/34300046
http://dx.doi.org/10.3390/ijerph18147595
work_keys_str_mv AT darlior theincidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT benshabatniv theincidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT tiosanoshmuel theincidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT watadabdulla theincidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT mcgonagledennis theincidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT komaneshterdoron theincidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT cohenarnon theincidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT bragazzinicolaluigi theincidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT amitalhoward theincidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT darlior incidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT benshabatniv incidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT tiosanoshmuel incidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT watadabdulla incidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT mcgonagledennis incidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT komaneshterdoron incidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT cohenarnon incidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT bragazzinicolaluigi incidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy
AT amitalhoward incidenceandpredictorsofsolidandhematologicalmalignanciesinpatientswithgiantcellarteritisalargerealworlddatabasestudy